Literature DB >> 19282512

The NBPF1 promoter has been recruited from the unrelated EVI5 gene before simian radiation.

Karl Vandepoele1, Vanessa Andries, Frans van Roy.   

Abstract

Most new genes arise through the duplication of existing genes. In most cases, the duplication is not limited to the coding sequence but encompasses the regulatory region as well. The NBPF gene family has expanded during recent primate evolution, and it has no known mouse ortholog. One of its members, NBPF1, was found to be disrupted by a constitutional translocation in a neuroblastoma patient. Here, we show that the ancestral NBPF gene copied the regulatory region from an unrelated gene, EVI5, after the split between simians and prosimians but before simian radiation. Phylogenetic analysis points to the possible involvement of positive selection acting on the NBPF1 promoter in the simian lineage. We previously showed decreased NBPF1 expression in certain neuroblastoma cell lines. Here, we show that this expression pattern is mimicked by the EVI5 gene, but partly by different mechanisms. Epigenetic regulation of the EVI5 promoter is common in neuroblastoma cell lines, but it is not for the NBPF promoters. Here, we describe the recent acquisition of the NBPF1 promoter from an unrelated gene, and remarkably, both the donor (EVI5) and acceptor (NBPF1) genes are disrupted by constitutional translocations in patients with neuroblastoma, suggesting a functional link between these genes and the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282512     DOI: 10.1093/molbev/msp047

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  9 in total

1.  DUF1220-domain copy number implicated in human brain-size pathology and evolution.

Authors:  Laura J Dumas; Majesta S O'Bleness; Jonathan M Davis; C Michael Dickens; Nathan Anderson; J G Keeney; Jay Jackson; Megan Sikela; Armin Raznahan; Jay Giedd; Judith Rapoport; Sandesh S C Nagamani; Ayelet Erez; Nicola Brunetti-Pierri; Rachel Sugalski; James R Lupski; Tasha Fingerlin; Sau Wai Cheung; James M Sikela
Journal:  Am J Hum Genet       Date:  2012-08-16       Impact factor: 11.025

2.  Evolutionary history and genome organization of DUF1220 protein domains.

Authors:  Majesta S O'Bleness; C Michael Dickens; Laura J Dumas; Hildegard Kehrer-Sawatzki; Gerald J Wyckoff; James M Sikela
Journal:  G3 (Bethesda)       Date:  2012-09-01       Impact factor: 3.154

3.  Different transcription activity of HERV-K LTR-containing and LTR-lacking genes of the KIAA1245/NBPF gene subfamily.

Authors:  Natalia Abrarova; Larisa Simonova; Tatyana Vinogradova; Eugene Sverdlov
Journal:  Genetica       Date:  2011-05-05       Impact factor: 1.082

4.  Evolutionary dynamism of the primate LRRC37 gene family.

Authors:  Giuliana Giannuzzi; Priscillia Siswara; Maika Malig; Tomas Marques-Bonet; James C Mullikin; Mario Ventura; Evan E Eichler
Journal:  Genome Res       Date:  2012-10-11       Impact factor: 9.043

5.  Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.

Authors:  Cemalettin Bekpen; Ibrahim Tastekin; Priscillia Siswara; Cezmi A Akdis; Evan E Eichler
Journal:  Genome Res       Date:  2012-03-14       Impact factor: 9.043

6.  Promoter reuse in prokaryotes.

Authors:  Harm Nijveen; Mariana Matus-Garcia; Mark Willem John van Passel
Journal:  Mob Genet Elements       Date:  2012-11-01

7.  The case for DUF1220 domain dosage as a primary contributor to anthropoid brain expansion.

Authors:  Jonathon G Keeney; Laura Dumas; James M Sikela
Journal:  Front Hum Neurosci       Date:  2014-06-24       Impact factor: 3.169

8.  Human core duplicon gene families: game changers or game players?

Authors:  Cemalettin Bekpen; Diethard Tautz
Journal:  Brief Funct Genomics       Date:  2019-11-19       Impact factor: 4.241

9.  Tumor-Suppressor Gene NBPF1 Inhibits Invasion and PI3K/mTOR Signaling in Cervical Cancer Cells.

Authors:  Yun Qin; Xicai Tang; Mingxing Liu
Journal:  Oncol Res       Date:  2016-01-21       Impact factor: 5.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.